arrow
A

Albert A. Davis

Mayo Clinic
H指数:29
被引数:4,598

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The North American Prodromal Synucleinopathy study: protocol for a multi-site, longitudinal, observational study of idiopathic/isolated rapid eye movement sleep behavior disorder

北美前驱期突触核蛋白病研究:一项多中心、纵向、观察性研究原发/孤立性快速眼动睡眠行为障碍的方案

2026-01-010
PRE
Quantifying Cognitive Change across One Year in REM Sleep Behavior Disorder: A Preliminary Analysis of North American Prodromal Synucleinopathy (NAPS) Consortium Study.

量化一年内REM睡眠行为障碍中的认知变化:一项北美前驱期突触核蛋白病(NAPS)联盟研究的初步分析。

2025-09-010
PRE
IGLON5 Frequency in Idiopathic REM Sleep Behavior Disorder
2024-11-010
PRE
Advancements in APOE and dementia research: Highlights from the 2023 AAIC Advancements: APOE conference

APOE和痴呆症研究的进展: 2023 AAIC进展的亮点: APOE会议

2024-07-191
OA
Frequency of Orthostatic Hypotension in Isolated REM Sleep Behavior Disorder The North American Prodromal Synucleinopathy Cohort
2023-12-124
PRE
An astrocyte BMAL1-BAG3 axis protects against alpha-synuclein and tau pathology

星形胶质细胞BMAL1-BAG3轴可防止 α-突触核蛋白和tau病理

NEURON
IF15
2023-08-0126
OAAI
CSF tau microtubule-binding region identifies pathological changes in primary tauopathies
2022-11-2446
OAAI
VCP suppresses proteopathic seeding in neurons
2022-04-1221
OAAI
Solving neurodegeneration: common mechanisms and strategies for new treatments

解决神经退行性疾病: 新疗法的常见机制和策略

2022-03-21123
OAAI
Functional genomic analyses uncover APOE-mediated regulation of brain and cerebrospinal fluid beta-amyloid levels in Parkinson disease
2020-11-198
OAAI